Kristina Ryzhikova

The impact of <em>ABCB1</em> (rs1045642 and rs4148738) and <em>CES1</em> (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty

Dmitriy Alekseevich Sychev, Tatiana Shelekhova, Kristina Ryzhikova et al. · Pharmacogenomics and Personalized Medicine · 2018 · 49 citations · Full text

Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery

Radik Minnigulov, Kristina Ryzhikova, Irina Y. Yudina · High Blood Pressure & Cardiovascular Prevention · 2019 · 36 citations

Rivaroxaban Pharmacokinetics, Pharmacology, Abcb1 Gene Polymorphisms +7

Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease

Dmitriy A. Sychev, Kristina Ryzhikova, Dmitriy V. Ivashchenko et al. · Drug Metabolism and Personalized Therapy · 2020 · 25 citations

Hypertension, Cardiovascular Disease, Dabigatran Etexilate +15

<em>CYP2C19</em> polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome

V. I. Ganyukov, Natalya Saraeva, Kristina Ryzhikova · Pharmacogenomics and Personalized Medicine · 2017 · 22 citations · Full text

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration

M. S. Zastrozhin, N. V. Baymeeva, Kristina Ryzhikova et al. · Drug Metabolism and Personalized Therapy · 2017 · 21 citations